baber/WOPTO huggingface dataset:
Patent MX-PA02006831-A (MX)
Title: Method for manfacturing composite deoxidizer of molten steel and the composite deoxidizer by using the method thereof.
Inventor: NAM CHUL WOO
IPC: C21C7/06
Filed: 2000-09-06
Abstract: The present invention relates to metallurgy and, in particular, the methods of the molten steel deoxidation and alloying with aluminium. According to the present invention there is provided a method of molten steel treating with Aluminium. Wherein the Aluminium is placed in the melt together with the Ironbased Alloy, and wherein the Aluminium and Ironbased Alloy are put into the Melt in the form of Composite with initial density which value is not less than 0.4, if compare to the molten steels density, and which contain Al, C, Si, Mn and Fe, and wherein range of ingredients is as follows (% of mass): Al 2550 C 0.050.90 Si 0.051.50 Mn 0. 151.25 Fe the Rest, by the way, the composite contains Aluminium as the matrix component and other ingredients in the form of Iron based alloy and as the reinforced component by the way the Aluminium Dissolution in the molten steel is realized by the continuous increasing of the composite relative density to the value of 1.001.05. Application of the present invention ensures efficiency improvement of the molten steel treatment with Aluminium assimilation and aluminium losses decreasing.
Patent MX-PA02007154-A (MX)
Title: Process for producing l lysine.
Inventor: KOJIMA HIROYUKI
IPC: C12N1/21
Filed: 2000-01-21
Abstract: L ysine is produced by culturing in an appropriate medium a bacterium belonging to the genus Escherichia which (1) carries dihydrodipicolinate synthase with the remission of the feedback inhibition by L lysine and aspartokinase with the remission of the feedback inhibition by L lysine; (2) has been potentiated in the intracellular activity of dihydrodipicolinate reductase; and (3) has diaminopimelate dehydrogenase gene transferred thereinto, or has been potentiated in the intracellular activities of tetrahydrodipicolinase succinylase and succinyldiaminopimelate deacylase, characterized by having been potentiated in the intracellular activity of aspartate semialdehyde dehydrogenase or phosphoenolpyruvate carboxylase, to thereby produce and accumulate L lysine in the culture medium and then collecting the L lysine therefrom.
Patent MX-PA02008531-A (MX)
Title: Composition for the prevention and or treatment of the cytotoxic effects induced by the use of immunosuppressive agents.
Inventor: CAVAZZA CLAUDIO
IPC: A23L33/15
Filed: 2001-02-20
Abstract: A composition is disclosed which is suitable for the prevention and or treatment of cell and tissue abnormalities of exogenous, toxic or metabolic origin and suitable for reducing the toxic effects of cyclosporin A and other immunosuppressive agents, which may take the form of a food supplement or of an actual medicine, containing as its active ingredients in combination or separately packaged: (a) propionyl L carnitine or one of its pharmacologically acceptable salts, and (b) an amino acid selected from the group consisting of glycine, serine, alanine and arginine, or mixtures thereof.
Patent MX-PA03001048-A (MX)
Title: Polymorphs of zaleplon and methods for the preparation thereof.
Inventor: COWANS BRETT
IPC: C07D487/04
Filed: 2001-08-02
Abstract: This invention relates to novel crystalline polymorphic forms of zaleplon (N-[3-(3-cyanopyrazolo[1, 5a]pyrimidin-7-yl)phenyl]-N-ethylacetamide), methods for the preparation thereof, and their uses as anxiolytic, antiepileptic, and sedative-hypnotic agents and skeletal muscle relaxants.
Patent MX-PA03002964-A (MX)
Title: Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases.
Inventor: RATH MATTHIAS
IPC: A61K9/02
Filed: 2001-10-03
Abstract: The present invention provides compositions and methods for lowering plasma Lp(a) levels in human. The present invention provides compositions and methods for lowering the risk factors for cardiovascular diseases. Moreover, this invention provides therapeutic alternatives to current pharmaceutical interventions for the lowering of cholesterol, LDL-cholesterol, triglycerides and other metabolic risk factors.
Patent MX-PA03004586-A (MX)
Title: Reactor for chemical conversion of a feedstock in the presence of a diluent, with heat inputs and feedstock/catalyst cross-circulation.
Inventor: LENGLET ERIC
IPC: B01J8/04
Filed: 2001-11-07
Abstract: The invention concerns a reactor (R) for chemical conversion in the presence of a gas diluent comprising between an upper end and a lower end a substantially vertical catalytic bed (3a, 3b, 3c) and comprising in combination proximate to its upper end at least means (9) for introducing a solid catalyst, means for introducing (1) and evacuating (2) said feedstock enabling its substantially horizontal circulation across the catalytic bed (3a, 3b, 3c), proximate to its lower end catalyst extracting means (7a, 7b, 7c, 8a, 8b, 8c), at least means for heating (4a, 4b) said feedstock to which said diluent has been added, said means (4a, 4b) being internal to the reactor (R) and traversed by said diluent-added feedstock in the absence of the catalyst, and separating the catalytic bed (3a, 3b, 3c) into an upstream part and a downstream part at said heating means (4a, 4b) relative to the feedstock circulating direction, comprising at least means for introducing a stream of said gas diluent (10a, 10b, 10c) substantially proximate to at least one of the upper and/or lower ends of said upstream part of the catalytic bed (3a, 3b), so as to at least reduce bypassing of said heating means by said diluent-added feedstock.
Patent MX-PA03005738-A (MX)
Title: Inks for in-mould decoration.
Inventor: N KUMAR MENON
IPC: C09D11/10
Filed: 2001-09-26
Abstract: An energy-cure ink or varnish composition is provided for use in an in-mould decoration (IMD) process, comprising an energy-curable resin, additional reactive monomers and/or oligomers and, optionally and in an amount not exceeding 10 % by weight, a solvent, wherein the resin comprises a urethane acrylate oligomer having an aromatic or aliphatic polycarbonate backbone. For inks, the composition additionally includes a pigment or dye. For photocure compositions, a photoinitiator is also included. Also provided is an in-mould decoration (IMD) process employing the ink or varnish composition.
Patent MX-PA03005964-A (MX)
Title: Arrangement for detecting temperature variations with accommodation for the related sensor.
Inventor: PIETRO MASSIMO REN
IPC: G01K1/14
Filed: 2001-12-01
Abstract: Arrangement that supports a temperature sensor comprising a terminal probe, applied on the outside of a preferably cylindrical body, and comprising an elastic ring arranged in contact with said body and provided with a hole accommodating said terminal probe; the elastic ring is interrupted by a split-like gap that increases the elastic adaptation ability thereof. Preferably, on the outside of said ring there is provided a perimetrical groove and said hole is obtained by appropriately shaping of inner surfaces of said groove. On the inside of the ring there may be provided a through-slit, so that the groove is capable of being spread apart in correspondence of said hole.
Patent MX-PA03010004-A (MX)
Title: Interface circuit.
Inventor: SCHWEIDLER SIEGFRIED
IPC: H04L12/56
Filed: 2002-04-18
Abstract: The invention deals with a wireless extension of the IEEE 1394 bus. Considered is a scenario where two clusters of 1394 devices are linked to each other by means of a wireless bridge (9). The devices of one cluster shall communicate with devices of the other cluster without being bridge-aware. The wireless bridge, however, provides for a bus reset isolation. This causes a problem each time a bus reset occurs in one of the clusters. To solve this problem it is proposed to implement a buffer memory (22) for self-identification packets in the 1394 interfaces (11) of both boxes of said wireless bridge (9). In particular these buffer memories (22) shall be implemented in the physical layer section (21) of the 1394 interfaces (11). With these buffer memories the self-identification packets of the bus stations in the other cluster can be collected and they can easily be read out during the self-configuration phase of the network after a bus reset when the bus grant is assigned to the box of the wireless bridge that is also connected to the bus where the bus reset has occurred. The physical layer section of the 1394 interface transmits artificial self-identification packets for all bus stations of the other cluster so that data communication can continue without long delays. <IMAGE>
Patent MX-PA03011201-A (MX)
Title: Modulators of peroxisome proliferator activated receptors.
Inventor: ROBERT J ARDECKY
IPC: C07D295/185
Filed: 2002-05-30
Abstract: Disclosed is a compound represented by Structural Formula (I): Ar is a substituted or unsubstituted aromatic group. Q is a covalent bond, -CH2-or-CH2CH2-; W is a substituted or unsubstituted alkylene or a substituted or unsubstituted heteroalkylene linking group from two to ten atoms in length, preferably from two to seven atoms in length. Phenyl Ring A is optionally substituted with up to four substituents in addition to R1 and W. R1 is (CH2)n-CH(OR2)-(CH2)mE, -(CH)=C(OR2)-(CH2)mE, -(CH2)n-CH(Y)-(CH2)mE or (CH)=C(Y)-(CH2)mE; wherein E is COOR3, C1-C3 alkylnitrile, carboxamide, sulfonamide, acylsulfonamide or tetrazole and wherein sulfonamide, acylsulfonamide and tetrazole are optionally substituted with one or more substituents independently selected from: C1-C6 alkyl, haloalkyl and aryl-C0-4-alkyl; R2 is H, an aliphatic group, a substituted aliphatic group, haloalkyl, an aromatic group, a substituted aromatic group, -COR4, -COOR4, -CONR5R6, -C(S)R4, -C(S)OR4 or C(S)NR5R6. R3 is H, an aliphatic group, a substituted aliphatic group, an aromatic group or a substituted aromatic group. Y is O-, CH2-, -CH2CH2- or CH=CH- and is bonded to a carbon atom in Phenyl Ring A that is ortho to R1. R4-R6 are independently H, an aliphatic group, a substituted aliphatic group, an aromatic group or a substituted aromatic group. n and m are independently 0, 1 or 2.
Patent MX-PA04005611-A (MX)
Title: Guanidinium transport reagents and conjugates.
Inventor: ROTHBARD JONATHAN B
IPC: A61K47/48
Filed: 2002-12-11
Abstract: Transport reagents and conjugates of therapeutic agents linked to transport reagents are described. In particular, the transport reagents have a plurality of guanidinium moieties that are either contiguous or spaced along a backbone, but are sufficiently removed from the backbone via tethers, to allow their interaction with a cell or tissue surface, leading to uptake of the therapeutic agent.
Patent MX-PA04007671-A (MX)
Title: System and method for processing work items according to an active work model.
Inventor: ABHAY S SHAH
IPC: G06Q10/10
Filed: 2003-01-20
Abstract: In one embodiment of the present invention, a system for processing work items includes a dispatcher operable to receive a plurality of messages and determine if any of the messages is associated with a work assignment. The system also includes an active work server communicatively coupled to the dispatcher and operable to receive work information associated with at least one message determined by the dispatcher to be associated with a work assignment. The active work server is further operable to create a work item associated with the at least one message based at least in part upon the work information, wherein the work item comprises an owner identifier. The active work server further communicates the work item to an owner associated with the owner identifier.
Patent MX-PA04009436-A (MX)
Title: Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases.
Inventor: KURNIT DAVID M
IPC: C12Q1/68
Filed: 2003-03-27
Abstract: The invention comprises novel compositions, systems, and methods for the analysis of biological samples, such as urine samples, in order to diagnose and treat kidney disease, including without limitation, glomerulonephritis, nephrotic syndrome, diabetes, lupus, hypertension, acute tubular necrosis, obstructive disorders of the urinary tract, renal cancers and other diseases or syndromes. In preferred embodiments, the invention comprises the identification of particular genes expressed only in cells of particular clinical or scientific interest in the urinary tract, such as podocytes or proximal tubule cells. Thus, the invention enables non-invasive, rapid and accurate analysis of kidney and urinary tract status and function in many medical diseases and disorders.
Patent MX-PA05007448-A (MX)
Title: Directional de-signature for seismic signals.
Inventor: GOTO RICHARD
IPC: G01V1/38
Filed: 2004-01-23
Abstract: The present invention provides a method and apparatus for directional de-signature of a seismic signal. The method includes forming a plurality of far-field signatures representative of a plurality of seismic signals having a plurality of take-off angles, associating a plurality of traces representative of a plurality of reflections of the seismic signals with the plurality of far-field signatures, and forming a plurality of de-signatured traces from the plurality of traces and the plurality of associated far-field signatures.
Patent MX-PA05009849-A (MX)
Title: Combined therapy comprising nemorubicin and a cyclooxygenase-2-inhibitor.
Inventor: SUARATO ANTONINO
IPC: A61K45/06
Filed: 2004-03-04
Abstract: The present Invention relates to the use of a morpholinyl anthracycline derivative, a pharmaceutically acceptable salt or a metabolite thereof, for the preparation of a medicament In combination with a Cox-2 Inhibitor for simultaneous, separate or sequential use for the treatment of cancer and to compositions or packaged units comprising a morpholinyl anthracycline derivative and a Cox-2 Inhibitor.
Patent MX-PA05011399-A (MX)
Title: Pyrimidine derivatives useful for the treatment of diseases mediated by crth2.
Inventor: SHINTANI TAKUYA
IPC: F16M11/28
Filed: 2004-04-14
Abstract: The present invention relates to a pyrimidine derivative of the formula (I) and salts thereof which is useful as an active ingredient of pharmaceutical preparations. The pyrimidine derivative of the present invention has excellent CRTH2 (G-protein-coupled chemoattractant receptor, expressed on Th2 cells) antagonistic activity and can be used for the prophylaxis and treatment of diseases associated with CRTH2 activity, in particular for the treatment of allergic diseases, such as asthma, allergic rhinitis, atopic dermatitis, and allergic conjunctivitis; eosinophil-related diseases, such as Churg-Strauss syndrome and sinusitis; basophil-related diseases, such as basophilic leukemia, chronic urticaria and basophilic leukocytosis in human and other mammals; and inflammatory diseases characterized by T lymphocytes and profuse leukocyte infiltrates such as psoriasis, eczema, inflammatory bowel disease, ulcerative colitis, Crohn's disease, COPD (chronic obstructive pulmonary disorder) and arthritis.
Patent MX-PA05011631-A (MX)
Title: Tilt-latch and window sash assembly.
Inventor: SILVERMAN ARTHUR
IPC: E05D15/22
Filed: 2003-04-30
Abstract: A window assembly is disclosed that allows a person to easily clean the exterior side of a windowpane, and prolongs the life of the window assembly. A window assembly (200) according to the present invention comprises a fixed window frame (202), tilt-latch assemblies (1, 2), and upper and lower window sashes (203, 204) comprised of a plurality of window sash rails, wherein each window sash rail has an outer wall (302), a front wall (300), and a rear wall (304). The tilt-latch assemblies (1, 2) secure the upper and lower window sashes (203, 204) within the fixed window frame (202). The tilt-latch assembly (1) is inserted into a slot (301) that is located on the outer wall (302) of the window sash rail for receiving a tilt-latch assembly (1). A lip (314) is located between a corner edge (212), wherein two sash rails meet to form a corner, and the outer edge (310) of the slot (308). The lip (314) can help prevent stress failure of the window sash rail.
Patent MX-PA05012345-A (MX)
Title: Pharmaceutical composition containing histone deacetylase inhibitor.
Inventor: MATSUBA YASUHIRO
IPC: A61K31/4745
Filed: 2004-05-26
Abstract: An anticancer drug having a synergistic effect by combined use of a histone acetylase derivative such as N-(2-aminophenyl)-4-[N-(pyridin-3-ylmethoxycarbonyl) aminomethyl]benzamide (MS-275) and another anticancer active substance.
Patent MX-PA05013874-A (MX)
Title: 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors.
Inventor: TERSTEEGEN ADRIAN
IPC: C07D239/42
Filed: 2004-06-16
Abstract: The invention relates to novel 6-arylamino-5-cyano-4-pyrimidinones of formula (I), methods for the production thereof, and the use thereof for producing medicaments utilized for improving awareness, concentration, learning capacity, and/or retentiveness of memory. Said compounds (I) show activity as PDE9 inhibitors.
Patent MX-PA06002152-A (MX)
Title: Condensed ring compound and use thereof.
Inventor: FUJITA MANABU
IPC: A61P11/06
Filed: 2004-08-31
Abstract: (I) (wherein all the symbols have the same meaning as in the description). This compound exhibits antagonism against cysLT2 receptor, so that it is useful as, for example, a preventive and/or therapeutic agent for respiratory diseases (for example, bronchial asthma, chronic obstructive lung disease, pulmonary emphysema, chronic bronchitis, pneumonia (e.g., interstitial myositis, etc.), severe acute respiratory syndrome (SARS), acute respiratory distress syndrome (ARDS), allergic rhinitis, sinusitis (e.g., acute sinusitis, chronic sinusitis, etc.), etc.), or as an expectorant agent or cough suppressant.
Patent MX-PA06003297-A (MX)
Title: The method of safe certification service.
Inventor: YANG KI-HO
IPC: G06F/
Filed: 2004-09-25
Abstract: The present invention relates to safe authentication. According to the present invention, a security access service method includes an authentication step by the input of text, an access location tracking step, an authentication step by the input of coordinates, and an access history report step.
Patent MX-PA06004121-A (MX)
Title: Flp-mediated recombination.
Inventor: CAAMANO LOUISA
IPC: C12N15/87
Filed: 2004-10-14
Abstract: Compositions and methods useful for homologous recombination and stable integration of a polynucleotide into a host cell are provided. The disclosed compositions and methods provide a rapid and efficient method for stably integrating an exogenous polynucleotide into a host cell and selecting such transformed cells.
Patent MX-PA06004264-A (MX)
Title: A multi-cell battery charge control.
Inventor: KLEIN MARTIN G
IPC: H01M50/569
Filed: 2004-10-15
Abstract: Embodiments of the present invention provide a method and system for controlling a multi-cell battery. In one embodiment of the present invention, a stack of bipolar wafer cells may be connected in series. Each cell may have an area that may be expandable in response to pressure. Such an area may be aligned with a corresponding area of at least one adjacent cell. The invention further includes a trigger mechanism that may be responsive to a force created by pressure generated in a cell in the stack of bipolar cells.
Patent MX-PA06005539-A (MX)
Title: Metal formwork with accessories for moulding concrete.
Inventor: GUSTAVO SERRANO RODRIGUEZ
IPC: E04G17/06
Filed: 2004-09-24
Abstract: The present invention relates to a formwork metallic form for molding concrete in construction works and substructure. The invention is easy to handle for numerous uses, with characteristic modules (10) to facilitate the connection between the panels by means of metal accessories. This metal formwork consists of modules which include steel sheets with reinforcements (12) and are sized according to the work requirements. This formwork, by virtue of the adjacent panels, imparts a shape to the concrete, especially walls, flagstones and mezzanine slabs. The panels are made of sheet steel (11) 2 to 3 mm thick and the conformed units can have a weight of up to 43 kilograms and dimensions that vary from 5 to 80 cm in width, and from 20 cm to 240 cm in height, with increments of 5 cm between the different measurements.
Patent MX-PA06013140-A (MX)
Title: Monoazo dyes.
Inventor: SCHOEFBERGER GEORG
IPC: C09B43/24
Filed: 2005-05-12
Abstract: Compounds of the general formula (I) (FORMULA SEE ENCLOSED PAPER COPY) a process for their preparation and their use for dyeing and/or printing organic substrates.
Patent MY-100617-A (MY)
Title: Stable nitrate/slurry explosives.
Inventor: JAMES HERMAN OWEN II
IPC: C06B31/28
Filed: 1986-11-03
Abstract: EXPLOSIVES THAT ARE SENSITIZED BLENDS OF INORGANIC NITRATE, E.G., AN, PARTICLES, SUCH AS AN OR ANFO PRILLS, AND AN AQUEOUS SLURRY COMPRISING A THICKENED AQUEOUS SOLUTION OF AN INORGANIC OXIDIZING SALT, PREFERABLY AN, ARE RENDERED STORAGE-STABLE BY KEEPING THE SLURRY''S WATER CONTENT LOW ENOUGH, AND ITS VISCOSITY HIGH ENOUGH, THAT THE SLURRY IS WATER-RETENTIVE. WATER IMMOBILIZATION IN THE SLURRY, A REQUIREMENT FOR STORAGE STABILITY, IS ACHIEVED DESPITE THE SLURRY'S FLOWABLE CONSISTENCY AT THE TIME OF BLENDING. A BLEND CONTAINING ABOUT 25% LURRY OR LESS, IS ESSENTIALLY IN THE FORM OF A GRANULAR MASS OF FREE-FLOWING, HIGH-DENSITY, SLURRY-BEARING PRILLS, AND THE SLURRY IS SENSITIZABLE BY THE PRILLS ALONE. AS THE SLURRY CONTENT EXCEEDS ABOUT 25%, THE BLEND TAKES ON THE CHARACTERISTICS OF A THRICK SLURRY, REQUIRING A SUPPLEMENTAL SENSITIZER IN THE SLURRY PER SE. SLURRIES CONTAINING A NITROGEN-BASE SALT OF AN INORGANIC OXIDIZING ACID, PREFERABLY MONOMETHYLAMINE NITRATE, ARE PREFERRED BECAUSE THIS ADDITIVE AFFORDS A SATURATED SOLUTION WITH LOWER WATER CONTENT, AND ALSO CAN ACT AS A SENSITIZER.
Patent MY-103778-A (MY)
Title: Set for the reproduction of data
Inventor: DIETER BAAS
IPC: G11B7/09
Filed: 1988-09-29
Abstract: A SET FOR REPRODUCTION OF DATA WHICH ARE DETECTABLE FROM THE DATA TRACKS OF AN INFORMATION CARRIER BY USING AN OPTICAL PICK-UP DEVICE. AT LEAST ONE LIGHT BEAM IS FOCUSED ON THE INFORMATION CARRIER USING A FOCUS CONTROL CIRCUIT AND USING A TRACK CONTROL CIRCUIT, THE SAID LIGHT BEAM CAN BE GUIDED ON A DATA TRACK. AS THE LIGHT BEAM IS REFLECTED OFF THE INFORMATION CARRIER TO A PHOTODECTECTOR, BY WHICH AN ELECTRICAL DATA SIGNAL, A FOCUS ERROR SIGNAL AS ACTUAL VALUE FOR THE FOCUS CONTROL CIRCUIT AND A TRACK SIGNAL AS ACTUAL VALUE FOR THE TRACK CONTROL CIRCUIT ARE GENERATED. THE CONTROL AMPLIFIERS (FR, TR) OF THE FOCUS CONTROL CIRCUIT AND THE TRACK CONTROL CIRCUIT ARE BUT SUBJECT TO AN OFF-SET VOLTAGE, WHICH VARIES WITH TEMPERATURE AND AGING OF THE CONTROL AMPLIFIERS. IN ORDER TO COMPENSATE THE OFF-SET VOLTAGE AUTOMATICALLY MEASURING PULSES OF ALTERNATING POLARITY ARE IMPRESSED ON THE CONTROL CIRCUIT AND THE TIMES ARE STORED AND COMPARED WITH EACH OTHER, WHICH PASS UNTIL THE PULS ANSWERS ARE EXCEEDING A THRESHOLD VALUE, WHICH IS PRE-SET. AN OFF-SET COMPENSATION VOLTAGE EXISTING AT THE INPUT OF THE CONTROL AMPLIFIERS (FR, TR) IS BEING AS LONG AS THE TIMES COMPARED WITH EACH OTHER FOR TWO PULS ANSWER FOLLOWING EACH OTHER ARE EQUAL.@@(FIG. 1)
Patent MY-105592-A (MY)
Title: Apparatus of manufacturing silicon single crystals.
Inventor: KENJI ARAKI
IPC: C30B15/14
Filed: 1990-03-26
Abstract: IN A SILICON SINGLE CRYSTAL MANUFACTURING APPARATUS OF THE TYPE WHICH CHARGES SILICON MATERIAL (16) CONTINUOUSLY, A HEAT RADIATION SHEILD (14) IS ARRANGED ABOVE A GROWING SECTION (B) TO SHIELD AND ADJUST THE RADIATION OF HEAT FROM THE SURFACE OF MOLTEN SILICON IN THE CRYSTAL GROWING SECTION. FOR REDUCING THE CONCENTRATION OF OXYGEN IN A SINGLE CRYSTAL, IT IS IMPORTANT TO SHIELD THE RADIATION OF HEAT FROM THE SURFACE OF THE MOLTEN SILICON. THE HEAT RADIATION SHIELD (14) WHICH IS COMPOSED OF A FIBROUS REFRACTORY, A FIBROUS REFRACTORY COVERED WITH A METAL PLATE, A MULTILAYER METAL SHEET ASSEMBLY OR AN ELECTRIC RESISTANCE HEATING ELEMENT IS ARRANGED ABOVE THE GROWING SECTION. ALSO, A PARTITION MEMBER (11) FORMED WITH SMALL HOLES (12) IS ARRANGED IN THE CRUCIBLE OR A QUARTZ PIPE IS ARRANGED ON THE INNER SIDE OF THE PARTITION MEMBER (11) TO EXTEND ALONG THE CIRCUMFERENTIAL DIRECTION THEREOF.(FIG. 1)